The use of mucolytic therapy in the treatment of infectious and inflammatory diseases of the respiratory tract
https://doi.org/10.21518/2079-701X-2018-20-36-42
Abstract
The article is devoted to the use of mucolytic therapy in the treatment of infectious and inflammatory diseases of the respiratory tract. Pathogen exposure results in an increase in the viscosity and adhesion of the respiratory tract mucus and leads to an impairment of drainage function and mucociliary clearance of the bronchi. Given the pathogenetic features, the primary goal of the treatment is to change the rheological properties of sputum and remove mucus from the respiratory tract. This justifies the administration of mucolytics, taking into account their pharmacological characteristics.
About the Authors
A. A. Krivopalov
Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Health of Russia, St. Petersburg
Russian Federation
Russian Federation
P. A. Shamkina
Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Health of Russia, St. Petersburg
Russian Federation
Russian Federation
References
1. Pratter M.R. Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. Chest, 2006, 129 (1): 63-71.
2. Nikolaeva SV, Usenko DV, Gorelov AV. New methods for the prevention of acute respiratory infections. Lechaschy Vrach, 2018, 2: 74-76.
3. Gembitskaya TE, Novikova LN, Chermensky AG. Acetylcysteine in acute and chronic respiratory diseases. Vrach, 2011, 3: 48-52.
4. Shatalina SI, Kolosova NG. Herbal remedies in the treatment of cough in children. RMJ. 2017, 19: 1371-1374.
5. Morozova SV, Svistushkin VM. Possibilities of phytotherapy in cold cough. Terapia, 2016, 1: 16-22
6. Lucas A.M., Douglas L.C. Principles underlying ciliary activity in the respiratory tract. Arch Otolaryng, 1984, 20: 518-541.
7. Fedoseev GB, Zhikharev SS. The main mechanisms of protection of the bronchopulmonary system. Bolezni Organov Dykhania, 1989, 1: 112-143.
8. Maev IV. Mucolytics in the treatment of chronic obstructive pulmonary disease. Novosti Meditsiny i Farmatsii, 2000, 15: 3-4.
9. Geppe NA, Malakhova AB. An integrated approach to the treatment and prevention of acute respiratory infections in children: A practical guide for practitioners. M., 2012: 1-47.
10. Knyazheskaya NP, Bobkov EV. Modern mucolytic therapy of respiratory diseases. RMJ, 2018, 3 (1): 30–35.
11. Samsygina GA, Zaitseva OV. Bronchitis in children. Expectorant and mucolytic therapy. A guide for practitioners. M., 1999: 1-36.
12. Soroka YuA. Mucolytic therapy in pediatric practice. Zdorovie Rebenka, 2010, 1 (22): 73-78.
13. Zaitseva OV. Mucolytic therapy in the combination treatment of respiratory diseases in children. Consilium medicum. Pediatria, 2002, 5 (10): 17–22.
14. Union of Pediatricians of Russia, International Fundation for Mother & Child Health. Scientific and Practical Program «Acute respiratory infections in children. Treatment and Prevention”. M., 2002.
15. Kuzmenko LG. Dry unproductive cough in children. Lechaschy Vrach, 2005, 08. Bronchopulmonology, symposium.
16. Orlova ES. Acetylcysteine in the treatment of cough in children: a combination of efficacy and safety. Praktika Pediatra, 2013, 6: 34-36.
17. Decramer M., Rutten-van Molken M., Dekhuijzen P.N. et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC CostUtility Study, BRONCUS): a randomised placebo-controlled trial. Lancet, 2005, 365: 1552-1560.
18. Ushkalova EA. Acetylcysteine in clinical practice: the present and prospects. Pharmateca, 2007, 17: 30–36
19. Kelly G.S. Clinical applications of N-acetylcysteine. Alt Medical Review, 1998, 24(2): 114– 127.
20. Duijvestijn Y.C.M., Mourdi N., Smuchny J. et al. Acetylcysteine and carbocysteine for acute upper and low respiratory tract infections in pediatric patients without chronic bronchopulmonary disease (Review). Cochrane Database Syst. Review, 2010, 9: 1–22.
21. Pikuza OI, Zakirova AM. Cough: approaches to the treatment of acute respiratory infections using acetylcysteine in children. RMJ, 2012, 12: 608-610.
22. Derbeneva ML, Guseva AL. Some aspects of the diagnosis and treatment of cough. Meditsinsky Sovet, 2016, 4: 64-67.
23. Berdnikova NG, Novikov KN, Klimova OYu, et al. The role of herbal remedies in the treatment of symptoms of acute and chronic bronchitis. RMJ. 2017, 25: 1868–1871.
24. Wienkotten N., Begrow F., Kinzinger U., Schierstedt D. The effect of thyme extract on beta 2-receptors and mucocilliary clearance. Planta Med, 2007, 73(7): 629–635.
25. Berger T. Tolerability and efficacy of a herbal combination preparation in children and adolescents with recurrent infections of the upper respiratory tract. MMW Fortschr Med, 2008, 26: 85–90.
26. Kotlukov VK, Kazakova TV, Ayrapetyan AS, Antipova NV. Therapeutic use of herbal extracts in cough in children with acute respiratory infections. Meditsinsky Sovet, 2015, 14: 45-47
27. Saldon A.E., Lamson D.W. Immune-modifying and antimicrobial effects of eucalyptus oil and simple inhalation devices. Alternative medicine review, 2010, 15(1): 123–127.
28. Kehrl W., Sonnemann U., Dethlefsen U. Therapy of acute nonpurulent rhinosinusitis with cineole: results of a double-blind, randomized, placebo-controlled trial. Laryngoscope, 2004, 114: 738-742.
29. Ovchinnikov AYu, Miroshnichenko NA, Ekaterinchev VA, Smirnov IV. Upper respiratory tract infections in children and adults: otorhinolaryngologist’s recommendations. RMJ, 2016, 26: 1739-1742.
30. Shadrin, OG, Gaiduchik GA. The efficacy and safety of inhalation treatment of acute bronchitis in children using Eucabal Balsam. Zdorovie Rebenka, 2012, 7 (42): 28–32.
Review
For citations:
Krivopalov AA, Shamkina PA. The use of mucolytic therapy in the treatment of infectious and inflammatory diseases of the respiratory tract. Meditsinskiy sovet = Medical Council. 2018;(20):36-42. (In Russ.) https://doi.org/10.21518/2079-701X-2018-20-36-42
Views:
815
Email this article 